Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002

被引:67
作者
Brooks, Richard
Woods, Christopher W.
Benjamin, Daniel K., Jr.
Rosenstein, Nancy E.
机构
[1] Durham VAMC, Infect Dis Serv 113, Durham, NC 27705 USA
[2] Duke Univ, Sch Med, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[5] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Atlanta, GA USA
关键词
D O I
10.1086/504804
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Outbreaks of meningococcal disease are infrequent but important public health events. We characterize outbreak-associated cases in the United States and compare them with sporadic disease. Methods. Outbreaks of meningococcal disease that occurred during the period of 1 July 1994 through 30 June 2002 were identified through state health departments, Centers for Disease Control and Prevention records, and a review of newspapers and the medical literature. Cases associated with outbreaks were compared with sporadic cases identified through population-based surveillance. Results. We identified 69 outbreaks of Neisseria meningitidis infection ( median, 9.5 outbreaks per year; range, 3-14 outbreaks per year), which involved 229 patients from 30 states. Forty-three ( 62%) of the outbreaks involved N. meningitidis serogroup C, 17 ( 25%) involved serogroup B, and 9 ( 13%) involved serogroup Y. Twenty-five outbreaks ( 36%) occurred in communities, and 44 ( 64%) were organization based, including 12 that occurred in colleges and universities, 19 that occurred in primary and secondary schools, and 8 that occurred in nursing homes. Vaccination campaigns ( with the A/C/Y/W-135 meningococcal polysaccharide vaccine) were conducted for 31 outbreaks ( 28 involving serogroup C and 3 involving serogroup Y). After controlling for age, serogroup, and clinical presentation, outbreak-associated cases were associated with a higher case-fatality rate than were sporadic cases ( 21% vs. 11%; odds ratio, 3.3; 95% confidence interval, 2.0-5.5). Conclusions. Outbreaks remain an important but infrequent public health issue, representing < 2% of all cases of meningococcal disease. However, given the increased case-fatality rate found among outbreak- related cases of N. meningitidis infection, additional investigation of factors that favor the transmission and virulence of outbreak-related strains is warranted.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 15 条
[1]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[2]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P13
[3]  
ARTENSTEIN MS, 1971, B WORLD HEALTH ORGAN, V45, P291
[4]   Effectiveness of meningococcal C conjugate vaccine in teenagers in England [J].
Bose, A ;
Coen, P ;
Tully, J ;
Viner, R ;
Booy, R .
LANCET, 2003, 361 (9358) :675-676
[5]   Clusters of meningococcal disease in school and preschool settings in England and Wales: what is the risk? [J].
Davison, KL ;
Andrews, N ;
White, JM ;
Ramsay, ME ;
Crowcroft, NS ;
Rushdy, AA ;
Kaczmarski, EB ;
Monk, PN ;
Stuart, JM .
ARCHIVES OF DISEASE IN CHILDHOOD, 2004, 89 (03) :256-260
[6]   Epidemic serogroup B meningococcal disease in Oregon - The evolving epidemiology of the ET-5 strain [J].
Diermayer, M ;
Hedberg, K ;
Hoesly, F ;
Fischer, M ;
Perkins, B ;
Reeves, M ;
Fleming, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (16) :1493-1497
[7]   SEROGROUP-C MENINGOCOCCAL OUTBREAKS IN THE UNITED-STATES - AN EMERGING THREAT [J].
JACKSON, LA ;
SCHUCHAT, A ;
REEVES, MW ;
WENGER, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (05) :383-389
[8]  
National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1
[9]  
PELTOLA H, 1982, LANCET, V2, P595
[10]   Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C [J].
Popovic, T ;
Schmink, S ;
Rosenstein, NA ;
Ajello, GW ;
Reeves, MW ;
Plikaytis, B ;
Hunter, SB ;
Ribot, EM ;
Boxrud, D ;
Tondella, ML ;
Kim, C ;
Noble, C ;
Mothershed, E ;
Besser, J ;
Perkins, BA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :75-85